Breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with histologically confirmed thoracic malignant tumors such as lung cancer, esophageal cancer, and breast cancer; 2. Age 18 to 70 years old; 3. Patients who plan to undergo radical concurrent chemoradiotherapy or radiotherapy; 4. KPS score >=70 or ECOG 0-2; 5. Leukocyte >=4.0×10^9/L, neutrophil >=2.0×10^9/L, platelet >=100×10^9/L, hemoglobin >=100g/L, normal liver and kidney function, and pulmonary function FEV1>=50%.
Exclusion criteria
Exclusion criteria: 1. Presence of distant metastatic organs; 2. Malignant pleural effusion; 3. History of other malignant tumors; 4. Combined with serious underlying diseases; 5. Patients with mental disorders, pregnancy, and lactation; 6. Presence of contraindications to radiotherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major Adverse Cardiovascular Events,MACE;Overall Survival, OS; | — |
Secondary
| Measure | Time frame |
|---|---|
| PFS (Progression-Free-Survival);Radiationpneumonia, RP;Radiation esophagitis, RE;Quality of life assessment; | — |
Countries
China
Contacts
Xuzhou Central Hospital